Jordan Zwick is the Chief Strategy Officer of InflaRx, responsible for leading corporate strategy, business & corporate development and investor relations. He has been instrumental in the public financings of the Company and co-manages the US entity, InflaRx Inc. Jordan has vast industry operational experience at companies such as Medtronic, Salix Pharmaceuticals and Bausch Health. As part of the team that sold Salix to Valeant Pharmaceuticals (now Bausch Health Companies) for $14.5B in 2015, Jordan eventually became head of strategy at the Salix business unit, responsible for leading all business development transactions, alliance management, strategic planning and portfolio management, playing a key role in the turnaround story of Bausch Health. He holds B.A., M.S. degrees from Florida Atlantic University and a M.B.A. from the University of San Francisco.